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b-Catenin is a unique intracellular protein functioning
as an integral component of the cell–cell adherens complex
and a principal signaling protein mediating canonical Wnt
signaling. Little is known about its function in adult kidneys
in the normal physiologic state or after acute kidney injury
(AKI). To study this, we generated conditional knockout
mice in which the b-catenin gene was specifically disrupted
in renal tubules (Ksp-b-cat/). These mice were
phenotypically normal with no appreciable defects in kidney
morphology and function. In the absence of b-catenin,
c-catenin functionally substituted for it in E-cadherin binding,
thereby sustaining the integrity of epithelial adherens
junctions in the kidneys. In AKI induced by ischemia
reperfusion or folic acid, the loss of tubular b-catenin
substantially aggravated renal lesions. Compared with
controls, Ksp-b-cat/ mice displayed higher mortality,
elevated serum creatinine, and more severe morphologic
injury. Consistently, apoptosis was more prevalent in kidneys
of the knockout mice, which was accompanied by increased
expression of p53 and Bax, and decreased phosphorylated
Akt and survivin. In vitro activation of b-catenin by Wnt1
or stabilization of b-catenin protected tubular epithelial
cells from apoptosis, activated Akt, induced survivin, and
repressed p53 and Bax expression. Hence, endogenous
b-catenin is pivotal for renal tubular protection after AKI by
promoting cell survival through multiple mechanisms.
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Acute kidney injury (AKI), often resulting from ischemic,
toxic, and septic insults, is a common kidney disorder
associated with high rate of morbidity and mortality.1,2
Although a number of cellular events may contribute to the
pathogenesis of AKI, excessive apoptosis of renal tubular
epithelial cells is increasingly recognized as a major mechan-
ism leading to tubular collapse and an abrupt decline in
kidney function.3 Tubular cell apoptosis is tightly controlled
by the delicate balance between pro- and anti-apoptotic
forces, in which Akt kinase, p53 transcription factor, and
proapoptotic Bax are key players.2,3 In this context, elucida-
tion of their regulation in vivo is essential for understanding
of the pathogenesis of AKI, as well as for designing rational
intervention strategies.
b-Catenin is a unique intracellular protein that possesses
distinctive, dual functions. In addition to playing a role in
establishing cell–cell adhesion as an integral component of
the adherens junction complex, b-catenin is also the
principal signaling protein that mediates the canonical
Wnt signaling.4,5 As a structural protein in the cell adherens
complex, b-catenin physically binds to and bridges
E-cadherin to actin cytoskeleton, thereby stabilizing the
cell adherens junction. As a signaling protein, b-catenin is
controlled in the cytoplasm under normal resting condi-
tions, and constitutively undergoes phosphorylation and
subsequent ubiquitin-mediated degradation. However, on
activation by its upstream signaling, b-catenin is stabilized
and translocates into the nucleus, where it binds to
members of the T-cell factor/lymphoid enhancer-binding
factor family of transcription factors, and drive the
expression of its target genes. Aside from Wnt signaling,
b-catenin activation is also regulated by other signal
pathways as well, such as integrin-linked kinase and
transforming growth factor-b1.6–9 In that regard, b-catenin
could serves as a converging downstream effector that
mediates the actions of multiple key intracellular signaling.
Not surprisingly, extensive studies have demonstrated that
b-catenin is essential in regulating diverse arrays of biologic
processes, such as organ development, tissue homeostasis,
and injury repair.5,10
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Activation of b-catenin signaling in a temporally and
spatially controlled manner is indispensible for nephron
formation and kidney development.11,12 Inappropriate acti-
vation of b-catenin, however, has been shown to implicate in
the pathogenesis of various chronic kidney diseases, such as
obstructive nephropathy, diabetic nephropathy, adriamycin
nephropathy, polycystic kidney disease, and chronic allograft
nephropathy.13–17 These results suggest that a properly
controlled b-catenin signaling is necessary and essential for
the maintenance of kidney tissue integrity and homeo-
stasis.18–20 b-Catenin is ubiquitously expressed, at low level,
in normal kidneys.14 However, little is known about its
function in adult kidneys in normal physiologic setting.
Furthermore, whether it has any role in regulating tissue
damage or protection after AKI is completely unknown.
In this study, we studied b-catenin expression in
mouse models of AKI, and investigated its function in
regulating tubular cell injury/survival in conditional knock-
out mice in which b-catenin is specifically ablated in renal
tubules. Our results suggest that endogenous b-catenin is
crucial for renal tubular protection after AKI, which is
primarily mediated by promoting cell survival through
multiple mechanisms.
RESULTS
Induction of b-catenin in renal tubules after AKI
We first examined the expression of b-catenin in AKI induced
by folic acid, a model characterized by renal tubule injury,
cell apoptosis, and acute renal failure.21–23 Immunohisto-
chemical staining demonstrated an increased b-catenin
protein in renal tubules at 2 days after folic acid injection
(Figure 1b), compared with the controls (Figure 1a).
Cytoplasmic and nuclear localization of b-catenin was clearly
evident in renal tubules (Figure 1b, arrowheads in the boxed
area), indicating its activation after AKI. To confirm this
finding, we quantitatively assessed renal b-catenin abundance
by using western blot analysis of whole kidney lysates. As
shown in Figure 1c and d, more than sixfold induction of b-
catenin abundance was observed in the injured kidneys after
folic acid injection, compared with the controls (Figure 1d).
Similar induction of b-catenin protein was also observed in
the AKI induced by renal ischemia/reperfusion injury (IRI;
data not shown).
To determine tubular segment specificity of b-catenin
induction in AKI, we used double immunostaining for
b-catenin (green) and various tubular markers (red) in the
kidneys after folic acid injection. As illustrated in Figure 1e,
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Figure 1 |Upregulation of renal b-catenin in mouse model of acute kidney injury induced by folic acid. (a, b) Immunohistochemical
staining shows the expression and localization of b-catenin in the kidneys at 2 days after folic acid injection. Arrowheads indicate
positive staining. Boxed area was enlarged. Bar¼ 50mm. (c, d) Western blots demonstrate renal b-catenin protein levels at 2 days after folic
acid injection. Representative western blot (c) and quantitative data (d) are presented. Numbers (1, 2, and 3) indicate each individual
animal in a given group. **Po0.01 vs. vehicle controls (n¼ 4). (e) Co-staining for b-catenin and tubular segment-specific markers in the
injured kidneys after folic acid injection. Immunofluorescence staining demonstrated the co-staining of b-catenin (green) and various
tubular markers (red) in the kidneys at 2 days after folic acid injection. Segment-specific tubular markers used are as follows:
proximal tubule, aquaporin-1 (AQP1); cortical thick ascending limb, Tamm-Horsfall glycoprotein (THP); distal tubule, thiazide-sensitive
NaCl cotransporter (TSC)/NCC; and collecting duct, aquaporin-3 (AQP3). Arrowheads indicate b-catenin-positive tubules. GAPDH,
glyceraldehyde-3-phosphate dehydrogenase.
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b-catenin protein was apparently detectable in all tubular
segments, including proximal tubule, cortical thick ascending
limb, distal tubule, and collecting duct epithelia in AKI after
folic acid injection.
Mice with tubule-specific ablation of b-catenin are
phenotypically normal
We sought to determine the potential role of endogenous
b-catenin in normal renal physiology and in regulating tissue
injury in AKI. To this end, we generated conditional
knockout mice in which b-catenin gene is specifically
disrupted in renal tubules by using the Cre-LoxP system.
Homozygous b-catenin–floxed mice were mated with Ksp-
Cre transgenic mice expressing Cre recombinase under the
control of Ksp-cadherin promoter. As shown in Figure 2a and
b, conditional knockout mice with tubule-specific ablation of
endogenous b-catenin (designated as Ksp-b-cat/) were
generated (genotype: b-catfl/fl, Cre; Figure 2b, lane 2). Age-
and sex-matched b-catenin–floxed mice (genotype: b-catfl/fl)
from the same litters were used as controls (Figure 2b, lane
1). To confirm conditional ablation of b-catenin, we
examined its expression in the kidneys after folic acid
injection, as renal b-catenin was induced in that setting
(Figure 1). As shown in Figure 2c, western blot analyses of
whole kidney lysates revealed a marked reduction of renal b-
catenin protein in Ksp-b-cat/ mice, comparing with the
controls. Immunohistochemical staining for b-catenin also
showed a tubule-specific reduction of b-catenin protein in
the kidneys of Ksp-b-cat/ mice (Figure 2d and e).
Mice with tubule-specific deletion of b-catenin (Ksp-b-
cat/) were phenotypically normal. There was no appreci-
able abnormality in kidney morphology of Ksp-b-cat/
mice (Figure 3a). Ksp-b-cat/ mice exhibited similar body
weights as the controls (Figure 3b). Kidney function, as
reflected by serum creatinine and urinary albumin, was
indistinguishable between Ksp-b-cat/ mice and the
controls (Figure 3c and d).
As b-catenin is known to bind to E-cadherin and mediates
epithelial adherent interaction, this prompted us to investi-
gate the reason why ablation of this protein has not resulted
in a defect at epithelial adherens junctions. As shown in
Figure 3e, co-immunoprecipitation demonstrates that b-
catenin physically interacted with E-cadherin in the control
kidneys. As expected, this interaction of b-catenin/E-
cadherin was reduced in the kidneys of Ksp-b-cat/ mice
(Figure 3e). Interestingly, the interaction between E-cadherin
and g-catenin, another member of the catenin family,
was markedly induced in Ksp-b-cat/ kidneys, compared
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Figure 2 |Generation of conditional knockout mice with tubule-specific ablation of endogenous b-catenin. (a) Experimental design
shows the strategy of crossbreeding of the b-catenin–floxed mice (b-catfl/fl) with Cre transgenic mice under the control of Ksp-cadherin
promoter (Ksp-Cre). Black boxes indicate the exons of b-catenin gene. Orange boxes denote LoxP site. (b) Genotyping of the mice by PCR
analysis of genomic DNA. Lane 1 shows the genotyping of the control mice used in this study (genotype: b-catfl/fl), whereas lane 2 denotes
the genotyping of the tubule-specific b-catenin knockout mice (genotype: b-cateninfl/fl, Cre), designated as Ksp-b-cat/. (c) Western blot
analyses demonstrated a substantial reduction of renal b-catenin protein in Ksp-b-cat/ mice. Kidney lysates were made from control and
Ksp-b-cat/ mice at 2 days after folic acid injection, and immunoblotted with specific antibodies against b-catenin and GAPDH,
respectively. Numbers (1, 2, and 3) indicate each individual animal in a given group. (d, e) Representative micrographs show renal b-catenin
staining in the control (d) and Ksp-b-cat/ (e) mice at 2 days after folic acid injection. Boxed areas in cortical and medullar regions are
enlarged. Arrowheads indicate renal tubules. Bar¼ 50 mm.
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with the controls (Figure 3e). The protein levels of g-catenin
and E-cadherin, however, were not changed in the Ksp-b-
cat/ kidneys (Figure 3f), indicating that the increased
association of E-cadherin/g-catenin is not due to their
upregulation. These results suggest that in the absence of
b-catenin, g-catenin functionally substitutes for its role in
maintaining the integrity of epithelial cell–cell adherens
junctions.
Tubule-specific ablation of b-catenin aggravates AKI
We next examined the effects of b-catenin ablation on acute
tubular injury after folic acid injection. Of interest, 9 out of
18 Ksp-b-cat/ mice died (50% mortality rate) within 2
days after folic acid administration, whereas only 4 out
of 17 control mice deceased (23.5% mortality rate) in the
same period under the identical conditions. This suggests
that loss of endogenous b-catenin increases mortality rate in
mice after AKI. In the surviving mice, serum creatinine
levels at 2 days after folic acid were significantly higher in
Ksp-b-cat/ mice than that in the controls (Figure 4a).
Accordingly, Ksp-b-cat/ kidneys exhibited more severe
morphological injury, particularly in the outer stripe of out
medulla region, characterized by loss of brush border, tubular
cell depletion, and cast formation in the lumen (Figure 4b,
yellow asterisks). Quantitative assessment of kidney mor-
phological injury between control and Ksp-b-cat/ groups
at 2 days after folic acid injection is presented in Figure 4c.
Together, it is clear that loss of endogenous b-catenin
aggravates tubular lesions and acute kidney failure induced
by folic acid.
Ablation of b-catenin promotes tubular cell apoptosis and
Bax expression
To explore the mechanism underlying the cytoprotective role
of endogenous b-catenin in AKI, we further examined
apoptotic cell death in the kidneys of control and Ksp-b-
cat/ mice after folic acid injection. As shown in Figure 5a,
terminal deoxynucleotidyl transferase–mediated dUTP nick-
end labeling (TUNEL) staining revealed considerable apop-
tosis in both cortical and medullar regions of the kidneys in
control mice at 2 days after folic acid administration.
However, the frequency of apoptosis in the Ksp-b-cat/
kidneys was significantly higher than that in the controls
under same conditions (Figure 5a, arrows). Quantitative data
on apoptotic cells in both cortical and medullar regions of
control and Ksp-b-cat/ mice are presented in Figure 5b.
These results suggest that tubule-specific loss of b-catenin
exacerbates kidney injury by promoting apoptosis.
We further examined renal expression and distribution of
Bax, a proapoptotic member of Bcl-2 family, in control and
Ksp-b-cat/ mice, as it is a central player in mediating
mitochondrial dysfunction and cell apoptosis.24,25 As shown
in Figure 5c and d, Bax protein was markedly increased in the
kidneys of Ksp-b-cat/ mice at 2 days after folic acid
injection, when compared with the controls. Immunohisto-
chemical staining also revealed a substantial increase of Bax
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Figure 3 |Mice with tubule-specific ablation of endogenous b-catenin are phenotypically normal. (a) Representative micrographs
show the morphology of control and Ksp-b-cat/ kidneys. Cortical and medullar regions were shown. Bar¼ 50mm. (b–d) There were
no differences in body weight (b), serum creatinine (c), and urinary albumin level (d) between control and Ksp-b-cat/ mice (n¼ 3).
(e) g-Catenin functionally compensates for the lost b-catenin at adherens junctions by augmenting interaction with E-cadherin in the
kidneys of Ksp-b-cat/ mice. Kidney lysates from control and Ksp-b-cat/ mice were immunoprecipitated (IP) with anti-E-cadherin
antibody, followed by immunoblotting (IB) with antibodies against b-catenin, g-catenin, and E-cadherin. (f) Loss of tubular b-catenin did not
affect the expression of g-catenin and E-cadherin in the kidneys. Kidney lysates were immunoblotted with antibodies against b-catenin,
g-catenin, E-cadherin, and actin. Ucr, urine creatinine.
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protein in renal tubules in the kidneys of Ksp-b-cat/ mice
(Figure 5e, arrowheads).
Ablation of endogenous b-catenin activates multiple
proapoptotic pathways
To elucidate the upstream signaling that is responsible for
Bax induction in Ksp-b-cat/ mice, we further examined
renal expression of p53, a tumor suppressor protein that
promotes apoptosis by regulating Bax expression.26 As shown
in Figure 6a and b, p53 protein was significantly upregulated
in the kidneys of Ksp-b-cat/ mice at 2 days after folic acid
injection, comparing with the controls. These data suggest
that p53 upregulation could be a potential upstream signaling
that leads to renal Bax induction in Ksp-b-cat/ mice after
injury.
Bax protein is also subjected to regulation by Akt-
mediated phosphorylation.27 Therefore, we also examined
the phosphorylation status of renal Akt in vivo. As shown in
Figure 6c, tubule-specific loss of b-catenin substan-
tially inhibited Akt phosphorylation at Serine 473 in the
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Figure 5 | Tubule-specific ablation of b-catenin promotes apoptosis and Bax expression after acute kidney injury. (a, b) Tubule-
specific loss of b-catenin aggravates apoptosis in acute kidney injury. (a) Representative micrographs show apoptotic cell death detected by
terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling staining. Arrows in the enlarged boxed areas indicate apoptotic
cells. Bar¼ 50mm. (b) Quantitative determination of apoptotic cells in renal cortical and medullar regions at 2 days after folic acid injection.
Data are presented as numbers of apoptotic cells per high power field (HPF). **Po0.01 (n¼ 4). (c, d) Loss of b-catenin promoted renal Bax
protein expression. Representative western blot data (c) and quantitative analysis (d) are presented. Numbers (1, 2, 3, and 4) indicate each
individual animal in a given group. *Po0.05 (n¼ 4). (e) Representative micrographs showed immunohistochemical staining for Bax in the
kidneys at 2 days after folic acid injection. Arrows indicate Bax-positive tubules in renal cortex and medulla. Bar¼ 50 mm.
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Ksp-b-cat/ mice, although total Akt abundance was
unaltered (Figure 6c and d).
We reasoned that in the setting of AKI, activated b-catenin
might also directly control the transcription of pro-
survival genes. In that regards, previous studies indicate
that survivin, a member of the inhibitors of apoptosis
proteins family that promotes cell survival by preventing
apoptosis,28,29 is a direct downstream target gene of
b-catenin.30,31 Hence, we examined survivin mRNA expres-
sion in the kidneys by quantitative, real-time RT-PCR (qRT-
PCR). As shown in Figure 6e, the steady-state level of
survivin mRNA in Ksp-b-cat/ mice at 2 days after folic
acid injection was significantly lower than that in the
controls. Altogether, as illustrated in Figure 6f, it becomes
clear that loss of b-catenin stimulates multiple signaling
pathways leading to tubular cell apoptosis after AKI.
Loss of tubular b-catenin also aggravates AKI induced by IRI
We also investigated the cytoprotective role of endogenous
b-catenin by using another model of AKI, renal IRI. At 1 day
after IRI, all control mice (n¼ 4) survived, while one out of
four Ksp-b-cat/ mice (n¼ 4) died. As shown in Figure 7a,
serum creatinine levels at 1 day after IRI were significantly
higher in Ksp-b-cat/ mice than that in the controls.
Ksp-b-cat/ kidneys also showed more severe morpholo-
gical injury, characterized by loss of brush border and tubular
cell loss (Figure 7b and c). Similarly, TUNEL staining also
exhibited more apoptosis in the kidneys after IRI in Ksp-b-
cat/ mice than that in the controls (Figure 7d and e).
Renal expression of Bax protein was markedly increased
in the kidneys of Ksp-b-cat/ mice at 1 day after IRI,
compared with the controls (Figure 7f and g). In short, these
results indicate that loss of endogenous b-catenin exacerbates
ischemic AKI as well.
Activation of b-catenin protects tubular cells against
apoptosis in vitro
To provide direct evidence that links the loss of b-catenin to
tubular cell apoptosis, we finally investigated the potential
role of b-catenin activation in regulating tubular cell survival
after injury by using in vitro system. For activating
endogenous b-catenin, human proximal tubular epithelial
cells (HKC-8) were transfected with the expression vector
encoding Wnt1, the prototype member of Wnt family that
activates b-catenin via canonical pathway. Previous studies
have shown that ectopic expression of Wnt1 causes
endogenous b-catenin activation in HKC-8 cells.32 As shown
in Figure 8a and b, significant apoptosis was observed in
HKC-8 cells after treatment with staurosporine (STS), a
potent apoptosis inducer,33,34 for a short period of incuba-
tion, as illustrated by TUNEL staining. However, transfection
of Wnt1 expression vector (pHA-Wnt1) completely pro-
tected HKC-8 cells from STS-induced apoptosis under same
conditions (Figure 8a and b).
Wnt1 also induced survivin mRNA expression in tubular
epithelial cells, as demonstrated by qRT-PCR (Figure 8c). As
shown in Figure 8d, tubular cell apoptosis induced by STS
was associated with Bax induction in HKC-8 cells. How-
ever, ectopic expression of Wnt1 substantially abolished Bax
induction in HKC-8 cells (Figure 8d). Consistent with the
in vivo data, activation of endogenous b-catenin by Wnt1 also
promoted Akt phosphorylation and inhibited p53 expression
in tubular cells after injury (Figure 8e). Similarly, ectopic
expression of exogenous b-catenin by transfecting of HKC-8
cells with N-terminally truncated, stabilized b-catenin ex-
pression vector (pDel-b-cat) also prevented STS-induced
apoptosis (Figure 8f), induced survivin mRNA expression
(Figure 8g), and abolished Bax induction (Figure 8h). These
data suggest that activation of b-catenin in vitro is sufficient
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(a, b) Western blot analyses demonstrated that tubule-specific ablation of endogenous b-catenin induced renal expression of p53 protein.
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for protecting tubular epithelial cells from apoptosis by
multiple mechanisms.
DISCUSSION
By generating conditional knockout mouse model in which
b-catenin is selectively ablated in renal tubules, the present
study represents the first attempt to elucidate the function of
endogenous b-catenin in normal renal physiology and in
regulating tubular cell damage/survival after acute injury.
Our data indicate that activation of b-catenin in the setting of
AKI is advantageous and renal protective, as tubule-specific
loss of endogenous b-catenin results in higher mortality rate,
elevated serum creatinine and worsened morphologic lesions
after folic acid and IRI (Figures 4 and 7). Furthermore, loss of
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regions at 1 day after renal ischemia/reperfusion injury. Data are presented as numbers of apoptotic cells per high power field (HPF).
**Po0.01 (n¼ 3). (f, g) Loss of b-catenin promoted renal Bax protein expression in ischemic AKI. Western blot (f) and quantitative analysis
(g) are presented. Numbers (1, 2 and 3) indicate each individual animal in a given group. *Po0.05 (n¼ 3). DAPI, 40-6-diamidino-2-
phenylindole.
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b-catenin also leads to an increased tubular cell apoptosis
after AKI, which is associated with an increased renal
expression of p53 and Bax, and decreased Akt phosphoryla-
tion and survivin expression (Figures 5 and 6). It should be
pointed out that the difference in renal injury and kidney
dysfunction between control and Ksp-b-cat/ groups is
mostly likely underestimated, because more mice with the
most severe AKI died selectively in the Ksp-b-cat/ group,
compared with the controls. These results clearly indicate
that activation of b-catenin in renal tubules after AKI is a
defensive response of the kidneys in an attempt to protect
against the catastrophic damage to tubule cells.
Kidney tubular cells are susceptible to various toxic and
metabolic injuries to undergo apoptotic cell death, mainly by
a mitochondria-dependent pathway. In AKI induced by folic
acid or IRI, tubular cell apoptosis is a major pathogenic
mechanism leading to acute renal failure.3,22 Because b-
catenin is a survival factor in vitro for tubular epithelial cells
(Figure 8),35 loss of b-catenin would eradicate an endogenous
survival mechanism that normally safeguards renal tubules,
leading to an exaggerated apoptosis after injury. This notion
is substantiated experimentally in two models of AKI induced
by folic acid (Figure 5) and IRI (Figure 7). However, we
cannot exclude the possibility that endogenous b-catenin
may also affect other forms of tubular cell death such as
necrosis and necroptosis after injury.3,36
Comparing to renal medulla, only a fraction of proximal
tubules in the cortical region in Ksp-b-cat/ kidneys
exhibited an increased TUNEL staining and Bax induction
(Figure 5). This is probably related to the unique expression
pattern of Cre recombinase in Ksp-Cre mice,37,38 which
closely imitates endogenous Ksp-cadherin, a tissue-specific
member of the cadherin family of cell adhesion mole-
cules.37,39 Although Cre is expressed in all segments of the
nephron and collecting ducts in Ksp-Cre mice, not all
proximal tubules express it.37,38 In fact, earlier studies using
reporter gene indicate that only 21% of proximal tubular
cells, but more than 92% of distal tubular and collecting duct
cells, actually express sufficient Cre to mediate the deletion of
a floxed DNA segment.38 This could result in an incomplete
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Figure 8 |Activation of endogenous b-catenin promotes kidney tubular cell survival in vitro. (a, b) Ectopic expression of exogenous
Wnt1 protects tubular cells against apoptosis induced by staurosporine (STS). HKC-8 cells were transfected with Wnt1 expression vector
(pHA-Wnt1) or empty vector (pcDNA3), followed by treatment with STS (1 mmol/l) for various periods of time as indicated. Apoptosis was
assessed by terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling (TUNEL) staining. Representative micrographs of
TUNEL staining (a) and quantitative data of apoptotic cells per high power field (HPF) (b) are presented. **Po0.01 vs. vehicle control (n¼ 3);
wPo0.05 vs. pcDNA3 control (n¼ 3). (c) Quantitative real-time RT-PCR showed that activation of endogenous b-catenin by Wnt1 induced
survivin mRNA expression in tubular epithelial cells. *Po0.05 (n¼ 3). (d, e) Ectopic expression of Wnt1 prevented Bax (d) and p53 (e)
expression induced by STS in tubular epithelial cells. Wnt1 also promoted Akt phosphorylation after STS incubation (e). (f–h) Ectopic
expression of stabilized b-catenin also prevented tubular cell apoptosis (f), induced survivin expression (g), and blocked STS-induced Bax
expression (h). HKC-8 cells were transfected with N-terminally truncated, stabilized b-catenin (pDel-b-cat) or empty vector (pcDNA3).
Apoptosis was assessed by TUNEL staining after incubation with STS (1 mmol/l) for 6 h (f). Survivin mRNA expression was detected by
qRT-PCR (g). Bax protein expression was assessed by western blot and quantified (h). *Po0.05 (n¼ 3).
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ablation of b-catenin in selective proximal tubules, thereby
contributing to the discriminatory apoptosis and Bax
induction in the cortical region of the Ksp-b-cat/ kidneys.
The present study indicates that activation of b-catenin
may promote tubular epithelial cell survival by a multitude of
mechanisms in vivo. Loss of b-catenin results in Bax
induction in renal tubules after injury, suggesting that Bax,
a proapoptotic member of Bcl-2 family proteins, may have a
critical role in mediating proapoptotic effect of b-catenin
ablation in vivo. This notion is in line with previous in vitro
studies,35 and is substantiated by the observations that either
activation of endogenous b-catenin by expressing Wnt1 or
ectopic expression of exogenous b-catenin effectively pre-
vents Bax induction and tubular epithelial cell apoptosis after
incubation with STS, an apoptosis inducer (Figure 8). It is
conceivable that p53, a tumor suppressor with proapoptotic
activity, could be an upstream regulator that is responsible
for Bax induction, as it is induced in Ksp-b-cat/ kidneys
as well after folic acid injury (Figure 6). It has been shown
that p53, as a transcription factor, regulates Bax by control-
ling its transcription.40 Furthermore, p53 also exerts its
proapoptotic activity in a transcription-independent manner
by interacting with Bax, which results in promotion of Bax
activation as well as its insertion into the mitochondrial
membrane.40,41
Loss of b-catenin also leads to reduction of Akt
phosphorylation and survivin expression, two pro-survival
signals. Akt, a protein kinase activated by phosphatidylino-
sitol 3-kinase, is an essential regulator of cell survival/
apoptosis.42 Although b-catenin might activate Akt through
stimulating its upstream phosphatidylinositol 3-kinase and/
or inducing its expression,35 our results indicate that b-
catenin ablation inhibits Akt phosphorylation, but does not
affect Akt abundance in vivo (Figure 6). As Akt can
phosphorylate Bax leading to its inactivation, a reduced
Akt phosphorylation would enhance the proapoptotic
activity of Bax. Similarly, survivin, a member of the inhibitors
of apoptosis proteins family proteins that promotes cell
survival by inhibiting caspase activity, is a direct transcription
target of b-catenin.31,43 Therefore, loss of b-catenin inevitably
reduces the expression of this survival gene. Taken together,
as summarized in Figure 6f, deletion of b-catenin in a tubule-
specific manner leads to an increased apoptosis after AKI by
multiple mechanisms. On one hand, b-catenin ablation
causes p53 induction and Akt inhibition, resulting in Bax
induction and activation, respectively, which lead to
subsequent activation of caspases (Figure 6f). On the other
hand, loss of b-catenin reduces survivin expression, thereby
effectively eliminating the negative inhibitor of caspases
(Figure 6f). Undoubtedly, these effects resulted from loss of
b-catenin would make tubular cells extremely vulnerable to
injury, leading to an enhanced tubular cell apoptosis. In
addition, as Akt is also involved in promoting tubular cell
proliferation,44 reduced Akt activation in b-catenin-deficient
tubules may contribute to AKI via an impaired renal
regeneration.
It is interesting to point out that b-catenin is also important
in mediating cell–cell adhesion, and is a constituent of adherens
junctions where it links E-cadherin to the actin cytoskeleton.
However, tubule-specific ablation of b-catenin seems not to
cause any phenotypic abnormality, suggesting that b-catenin is
dispensable for maintaining the tubular integrity and home-
ostasis in adult kidneys. This observation is also in line with
recent reports demonstrating that genetic deletion of b-catenin
in various tissues including glomerular podocytes, hepatocytes,
and cardiomyocytes does not cause significant pathologic
lesions.13,45–47 Although b-catenin is a component of cell
adherens junction complex, our studies indicate that its
function as a structural protein can be substituted by g-
catenin, also known as plakoglobin, a structurally related
protein that also binds to E-cadherin (Figure 3e).46,47
In summary, we report herein that b-catenin is induced in
mouse models of AKI induced by folic acid or IRI, and loss of
endogenous b-catenin in a tubule-specific manner aggravates
kidney injury by promoting apoptosis via multiple mechan-
isms. These findings suggest that renal activation of b-catenin
after AKI is a protective response in attempt to minimize cell
damage. This seems in sharp contrast to the setting of chronic
kidney diseases, in which sustained activation of b-catenin
after chronic injury is shown to lead to tubular epithelial–
mesenchymal transition and renal fibrogenesis.17,19,20 There-
fore, a better understanding of the role and mechanism of
endogenous b-catenin signaling in different settings would be
essential for designing rational strategies for therapeutic
interventions. Clearly, more studies are needed in this area.
MATERIALS AND METHODS
Mice and genotyping
Homozygous b-catenin–floxed mice (C57BL/6J background) were
obtained from the Jackson Laboratories (Bar Harbor, ME), as
described previously.13 Transgenic mice that expressed Cre recombi-
nase under the control of kidney-specific Ksp-cadherin promoter
(ksp-Cre) was reported elsewhere.37 By mating b-catenin–floxed mice
with Ksp-Cre transgenic mice, conditional knockout mice (Ksp-b-
cat/) in which b-catenin gene was specifically disrupted in renal
tubular epithelial cells (genotype b-catfl/fl, Creþ /) were created.
These mice were crossbred with homozygous b-catenin–floxed mice
(genotype b-catfl/fl) to generate offspring with 50% Ksp-b-cat/
mice and 50% control mice (b-catenin–floxed mice) within the
same litters. A routine PCR protocol was used for genotyping
of tail DNA samples with the following primer pairs: Cre transgene,
50-AGGTGTAGAGAAGGCACTTAGC-30 and 50-CTAATCGCCATCT
TCCAGCAGG-30, which generated a 411-bp fragment; and b-catenin
genotyping, 50-AAGGTAGAGTGATGAAAGTTGTT-30 and 50-CACC
ATGTCCTCTGTCTATTC-30, which yielded a 324-bp band for the
floxed alleles. All animals were born normally at the expected
Mendelian frequency; and they were normal in size and did not
display any gross physical or behavioral abnormalities. Animal
experiments were approved by the Institutional Animal Care and
Use Committee at the University of Pittsburgh.
Mouse models of AKI
AKI in mice was induced by a single intraperitoneal injection of folic
acid (Sigma, St Louis, MO) dissolved in 150 mmol/lsodium
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bicarbonate (vehicle) at 250 mg/kg body weight, as described
previously in rats.21 At 48 h after injection, mice were killed, and
serum and kidney samples were collected for various analyses. We
also used another AKI model by inducing renal IRI.36 Briefly, after
mice were anesthetized, a midline abdominal incision was made and
bilateral renal pedicles were clipped for 35 min using microaneur-
ysm clamps. After removal of the clamps, reperfusion of the kidneys
was visually confirmed. The incision was then closed and the animal
was allowed to recover. During the ischemic period, body
temperature was maintained between 35 and 37.5 1C using a
temperature-controlled heating system. Blood and tissue samples
were obtained at 24 h post-IRI.
Determination of serum creatinine
Serum was collected from mice at 48 h after folic acid injection.
Serum creatinine level was determined by use of a QuantiChrom
creatinine assay kit, according to the protocols specified by the
manufacturer (BioAssay Systems, Hayward, CA). The level of serum
creatinine was expressed as milligrams per 100 ml (dl).
Histology and immunohistochemical staining
Paraffin-embedded mouse kidney sections (3-mm thickness) were
prepared by a routine procedure. The sections were stained with
hematoxylin-eosin, periodic acid–Schiff reagent by standard proto-
col. Immunohistochemical staining was performed according to the
established protocol as described previously.19 The antibodies used
were as follows: rabbit polyclonal to b-catenin (ab15180; Abcam,
Cambridge, MA) and rabbit polyclonal to Bax (sc-493; Santa Cruz
Biotechnology, Santa Cruz, CA).
Immunofluorescence staining and confocal microscopy
Kidney cryosections were fixed with 3.7% paraformalin for 15 min at
room temperature and immersed in 0.2% Triton X-100 for 10 min.
After blocking with 10% donkey serum in phosphate-buffered saline
for 1 h, slides were double immunostained with anti-b-catenin and
one of the following antibodies: anti-aquaporin 1 (AQP1; sc-9878,
Santa Cruz Biotechnology), anti-aquaporin 3 (AQP3; AB2219,
Millipore, Billerica, MA), anti-Tamm-Horsfall protein (THP; sc-
19554, Santa Cruz Biotechnology), or anti-Thiazide-sensitive Nacl
Cotransporter (NCC; AB3553, Millipore) to determine b-catenin
expression in different tubule segments, as described previously.48
To visualize the primary antibodies, slides were stained with
cyanine Cy2- or Cy3-conjugated secondary antibodies (Jackson
ImmunoResearch Laboratories, West Grove, PA). Stained slides were
viewed under a Leica TCS-SL confocal microscope equipped with a
digital camera (Leica, Buffalo Grove, IL).
Detection of apoptotic cells
Apoptotic cell death was determined by using TUNEL staining with
DeadEnd Colorimetric or Fluorometric Apoptosis Detection System
(Promega, Madison, WI), as described previously.49
Real-time RT-PCR
Total RNA isolation and real-time RT-PCR were carried out by the
procedures described previously.20 Briefly, the first strand cDNA
synthesis was carried out by using a reverse transcription system kit
according to the instructions of the manufacturer (Promega). qRT-PCR
was performed on ABI PRISM 7000 sequence detection system
(Applied Biosystems, Foster City, CA) as described previously.20 The
sequences of the primer pairs were as follows: mouse survivin, 50-GT
TTGAGTCGTCTTGGCG-30 (sense) and 50-TCAGGCTCGTTCTC
GGTA-30 (anti-sense); human survivin, 50-GCACCACTTCCAGGGTT-
TATTC-30 (sense) and 50-TCTCCTTTCCTAAGACATTGCTAAGG-30.
PCR was run by using standard conditions. The mRNA levels of
various genes were calculated after normalizing with b-actin.
Western blot analysis
Kidney tissues were lysed with radioimmune precipitation assay buffer
containing 1% NP-40, 0.1% SDS, 100mg/ml phenylmethanesulfonyl
fluoride, 1% protease inhibitor cocktail, and 1% phosphatase I and
II inhibitor cocktail (Sigma) in phosphate-buffered saline on ice.
The supernatants were collected after centrifugation at 13,000 g at
4 1C for 15 min. Protein expression was analyzed by western blot
analysis as described previously.33 The primary antibodies used were
as follows: anti-b-catenin (#610154; BD Transduction Laboratories,
San Jose, CA), anti-Akt (#4685), anti-phospho-Akt (Ser473) (#4060),
anti-E-cadherin ((#3195), anti-g-catenin (#2309) (Cell Signaling
Technology, Danvers, MA), anti-Bax (sc-493), anti-p53 (sc-6243),
anti-actin (sc-1616) (Santa Cruz Biotechnology), and anti-GAPDH
(AM4300; Ambion, Austin, TX).
Co-immunoprecipitation
Co-immunoprecipitation was carried out by using an established
method.50 Briefly, kidneys from control and Ksp-b-cat/ mice
were lysed on ice in 1 ml of non-denaturing lysis buffer that
contained 1% Triton X-100, 0.01 mol/l Tris-HCl (pH 8.0), 0.14 mol/l
NaCl, 0.025% NaN3, 1% protease inhibitors cocktail, and 1%
phosphatase inhibitors cocktail I and II (Sigma). After preclearing
with normal IgG, kidney lysates (0.5 mg of protein) were incubated
overnight at 4 1C with 2 mg of anti-E-cadherin (#610182; BD
Transduction Laboratories, San Jose, CA), followed by precipitation
with 100 ml of protein A/G Plus-agarose for 3 h at 4 1C. The
precipitated complexes were separated on SDS–polyacrylamide gel
electrophoresis and immunoblotted with specific antibodies against
E-cadherin (#3195; Cell Signaling Technology), b-catenin (#610154;
BD Transduction Laboratories) and g-catenin (#2309, Cell Signaling
Technology), respectively.
Cell culture and transfection
Human proximal tubular epithelial cell line (HKC, clone 8) was
provided by Dr L Racusen of the Johns Hopkins University
(Baltimore, MD). Cells were maintained as described previously.9
Serum-starved HKC-8 cells were transfected with Wnt1 expression
vector (pHA-Wnt1), N-terminally truncated, constitutively active b-
catenin expression vector (pDel-b-cat), or empty plasmid pcDNA3,
respectively. For some experiments, the transfected cells were
collected at 24 and 48 h after transfection, and total RNA was
prepared for qRT-PCR analysis. The transfected cells were also
treated at 48 h after transfection with 1 mmol/l STS (S4400; Sigma)
for various periods of time as indicated to induce apoptosis, and
then subjected to TUNEL staining and western blot analyses,
respectively.
Statistical analyses
All data were expressed as mean±s.e.m. Statistical analysis of the
data was performed using SigmaStat software (Jandel Scientific
Software, San Rafael, CA). Comparison between groups was made
using one-way ANOVA, followed by the Student–Newman–Keuls
test. Po0.05 was considered significant.
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